全文获取类型
收费全文 | 1561篇 |
免费 | 112篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 47篇 |
妇产科学 | 22篇 |
基础医学 | 253篇 |
口腔科学 | 10篇 |
临床医学 | 148篇 |
内科学 | 258篇 |
皮肤病学 | 28篇 |
神经病学 | 192篇 |
特种医学 | 93篇 |
外科学 | 114篇 |
综合类 | 10篇 |
一般理论 | 6篇 |
预防医学 | 158篇 |
眼科学 | 19篇 |
药学 | 132篇 |
中国医学 | 1篇 |
肿瘤学 | 143篇 |
出版年
2023年 | 14篇 |
2022年 | 25篇 |
2021年 | 55篇 |
2020年 | 37篇 |
2019年 | 32篇 |
2018年 | 46篇 |
2017年 | 35篇 |
2016年 | 35篇 |
2015年 | 43篇 |
2014年 | 49篇 |
2013年 | 66篇 |
2012年 | 91篇 |
2011年 | 120篇 |
2010年 | 54篇 |
2009年 | 54篇 |
2008年 | 98篇 |
2007年 | 75篇 |
2006年 | 92篇 |
2005年 | 70篇 |
2004年 | 96篇 |
2003年 | 73篇 |
2002年 | 75篇 |
2001年 | 23篇 |
2000年 | 21篇 |
1999年 | 8篇 |
1998年 | 17篇 |
1997年 | 10篇 |
1996年 | 14篇 |
1995年 | 11篇 |
1994年 | 7篇 |
1993年 | 14篇 |
1992年 | 14篇 |
1991年 | 10篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 14篇 |
1987年 | 7篇 |
1986年 | 14篇 |
1985年 | 6篇 |
1983年 | 10篇 |
1982年 | 8篇 |
1981年 | 12篇 |
1980年 | 7篇 |
1978年 | 6篇 |
1977年 | 11篇 |
1975年 | 9篇 |
1973年 | 5篇 |
1968年 | 6篇 |
1967年 | 4篇 |
1963年 | 4篇 |
排序方式: 共有1675条查询结果,搜索用时 31 毫秒
51.
52.
53.
Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Immunology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Type 1 interferon-beta (T1IFN-beta) is an innate cytokine and the first-choice therapy for multiple sclerosis (MS). It is still unclear how T1IFN-beta, whose main function is to promote innate immunity during infections, plays a beneficial role in autoimmune disease. Here we show that T1IFN-beta promoted the expansion and function of invariant natural killer (iNKT) cells, an innate T-cell subset with strong immune regulatory properties that is able to prevent autoimmune disease in pre-clinical models of MS and type 1 diabetes. Specifically, we observed that T1IFN-beta treatment significantly increased the percentages of Valpha24(+) NKT cells in peripheral blood mononuclear cells of MS patients. Furthermore, iNKT cells of T1IFN-beta-treated individuals showed a dramatically improved secretion of cytokines (interleukins 4 and 5 and interferon-gamma) in response to antigenic stimulation compared to iNKT cells isolated from the same patients before T1IFN-beta treatment. The effect of T1IFN-beta on iNKT cells was mediated through the modulation of myeloid dendritic cells (DCs). In fact, DCs modulated in vivo or in vitro by T1IFN-beta were more efficient antigen-presenting cells for iNKT cells. Such a modulatory effect of T1IFN-beta was associated with up-regulation on DCs of key costimulatory molecules for iNKT (i.e. CD80, CD40 and CD1d). Our data identified the iNKT cell/DC pathway as a new target for the immune regulatory effect of T1IFNs in autoimmune diseases and provide a possible mechanism to explain the clinical efficacy of T1IFN-beta in MS. 相似文献
54.
55.
56.
57.
58.
59.
60.
Takeda H Takami M Oguni T Tsuji T Yoneda K Sato H Ihara N Itoh T Kata SR Mishina Y Womack JE Moritomo Y Sugimoto Y Kunieda T 《Proceedings of the National Academy of Sciences of the United States of America》2002,99(16):10549-10554
Chondrodysplastic dwarfism in Japanese brown cattle is an autosomal recessive disorder characterized by short limbs. Previously, we mapped the locus responsible for the disease on the distal end of bovine chromosome 6. Here, we narrowed the critical region to approximately 2 cM by using linkage analysis, constructed a BAC and YAC contig covering this region, and identified a gene, LIMBIN (LBN), that possessed disease-specific mutations in the affected calves. One mutation was a single nucleotide substitution leading to an activation of a cryptic splicing donor site and the other was a one-base deletion resulting in a frameshift mutation. Strong expression of the Lbn gene was observed in limb buds of developing mouse embryos and in proliferating chondrocytes and bone-forming osteoblasts in long bones. These findings indicate that LBN is responsible for bovine chondrodysplastic dwarfism and has a critical role in a skeletal development. 相似文献